WRF
NXTM

Waddell & Reed Financial’s NxStage Medical Inc. NXTM Stock Holding History

Waddell & Reed Financial’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,247,271
Closed -$31.3M – 565
2017
Q2 		$31.3M Buy
1,247,271
+173,422
+16% +$4.29M 0.07% 299
2017
Q1 		$28.8M Sell
1,073,849
-38,770
-3% -$1.07M 0.06% 305
2016
Q4 		$29.2M Buy
1,112,619
+25,850
+2% +$639K 0.06% 291
2016
Q3 		$27.2M Buy
1,086,769
+864,051
+388% +$20.1M 0.06% 280
2016
Q2 		$4.83M Buy
+222,718
New +$3.97M 0.01% 475

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Waddell & Reed Financial's NXTM Position: Q3 2017 in Review

Waddell & Reed Financial sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 1,247,271 shares — an estimated $31.3M sold.

Waddell & Reed Financial first reported a position in NXTM in Q2 2016 and held it in 5 quarters. The position peaked at $31.3M in Q2 2017. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Waddell & Reed Financial reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Waddell & Reed Financial sold 1,247,271 NxStage Medical Inc. shares in Q3 2017, an estimated $31.3M.
  • Waddell & Reed Financial first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 5 quarters.
  • Waddell & Reed Financial's NxStage Medical Inc. position peaked at $31.3M in Q2 2017.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Waddell & Reed Financial's 13F filing for Q3 2017, filed 14 Nov 2017.